ONO oncology:オノオンコロジー

オノオンコロジー

オノオンコロジー

胃がん、肺がん、大腸がんなど、各種がんの治療に関する情報や、患者さん、ご家族の心や暮らしをサポートする情報、オプジーボ、カイプロリス、イメンド、ビラフトビ、 ...。其他文章還包含有:「Oncology」、「小野薬品のオンコロジー情報サイト(ONOONCOLOGY...」、「RisingtothechallengesofImmuno」、「NewImmuno」、「TurbineEstablishesResearchCollaborationwithOno...」、「ONO」、「Bristol」、「PhaseIStudyofAnti-Pd」

查看更多 離開網站

Ono Pharma台灣小野藥品Otsuka PharmaceuticalONO medical小野藥品104小野製藥Ono pharmaceutical
Provide From Google
Oncology
Oncology

https://us.ono-pharma.com

ONO has been a leader in oncology research for decades, challenging traditional thinking and bringing innovative therapeutics from bench to bedside.

Provide From Google
小野薬品のオンコロジー情報サイト(ONO ONCOLOGY ...
小野薬品のオンコロジー情報サイト(ONO ONCOLOGY ...

https://www.ono-oncology.jp

本ウェブサイトは、医療関係者の方を対象に小野薬品の製品に関する情報などを提供することを目的としています。

Provide From Google
Rising to the challenges of Immuno
Rising to the challenges of Immuno

https://www.ono-pharma.com

Ono today announced that it will begin airing its new commercial “Rising to the challenges of Immuno-Oncology” in Japan from October 2, 2024.

Provide From Google
New Immuno
New Immuno

https://bio.mx

ONO focuses its research on oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery ...

Provide From Google
Turbine Establishes Research Collaboration with Ono ...
Turbine Establishes Research Collaboration with Ono ...

https://turbine.ai

“Ono has a history of developing transformative cancer therapies, including its important role in launching Opdivo (nivolumab), the first ever ...

Provide From Google
ONO
ONO

https://www.youtube.com

Provide From Google
Bristol
Bristol

https://news.bms.com

“Ono's Prostaglandin E2 receptor antagonist programs offer the potential to develop targeted therapies that counteract the effects of an ...

Provide From Google
Phase I Study of Anti-Pd
Phase I Study of Anti-Pd

https://www.annalsofoncology.o

This phase I study investigated the tolerability, safety and pharmacokinetics of ONO-4538 in combination with chemotherapy in Japanese patients with advanced ...